+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Respiratory Disease Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4848109
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
The report on the global respiratory disease vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global respiratory disease vaccine market to grow with a CAGR of 9.7% over the forecast period from 2019-2025. The study on respiratory disease vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on respiratory disease vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global respiratory disease vaccine market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global respiratory disease vaccine market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Increasing prevalence of respiratory disorders
  • Growing number of vaccines in pipeline
2) Restraints
  • Stringent approval criteria
3) Opportunities
  • Increasing R&D expenditure by key market players
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global respiratory disease vaccine market is segmented on the basis of disease type, and vaccine.

The Global Respiratory Disease Vaccine Market by Disease Type
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pertussis
  • Pneumonia
  • Measles
  • Diphtheria
The Global Respiratory Disease Vaccine Market by Vaccine
  • DTaP
  • PPSV23
  • MMR
  • Haemophilus Influenzae Type B (Hib)
  • Respiratory Syncytial Virus (RSV)
Company Profiles

The companies covered in the report include
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Serum institute of India Private Limited
  • Others
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the respiratory disease vaccine market.
2. Complete coverage of all the segments in the respiratory disease vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global respiratory disease vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Respiratory Disease Vaccine Market Highlights
2.2. Respiratory Disease Vaccine Market Projection
2.3. Respiratory Disease Vaccine Market Regional Highlights

3. Global Respiratory Disease Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Disease Type
3.4.2. Growth Matrix Analysis by Vaccine
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Respiratory Disease Vaccine Market

4. Respiratory Disease Vaccine Market Macro Indicator Analysis

5. Global Respiratory Disease Vaccine Market by Disease Type
5.1. Chronic Obstructive Pulmonary Disease (COPD)Pertussis
5.2. Pneumonia
5.3. Measles
5.4. Diphtheria

6. Global Respiratory Disease Vaccine Market by Vaccine
6.1. DTaP
6.2. PPSV23
6.3. MMR
6.4. Haemophilus Influenzae Type B (Hib)
6.5. Respiratory Syncytial Virus (RSV)

7. Global Respiratory Disease Vaccine Market by Region 2019-2025
7.1. North America
7.1.1. North America Respiratory Disease Vaccine Market by Disease Type
7.1.2. North America Respiratory Disease Vaccine Market by Vaccine
7.1.3. North America Respiratory Disease Vaccine Market by Country
7.2. Europe
7.2.1. Europe Respiratory Disease Vaccine Market by Disease Type
7.2.2. Europe Respiratory Disease Vaccine Market by Vaccine
7.2.3. Europe Respiratory Disease Vaccine Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Respiratory Disease Vaccine Market by Disease Type
7.3.2. Asia-Pacific Respiratory Disease Vaccine Market by Vaccine
7.3.3. Asia-Pacific Respiratory Disease Vaccine Market by Country
7.4. RoW
7.4.1. RoW Respiratory Disease Vaccine Market by Disease Type
7.4.2. RoW Respiratory Disease Vaccine Market by Vaccine
7.4.3. RoW Respiratory Disease Vaccine Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Respiratory Disease Vaccine Market
8.2. Companies Profiled
8.2.1. Sanofi S.A.
8.2.2. GlaxoSmithKline plc
8.2.3. Merck & Co., Inc.
8.2.4. Pfizer Inc.
8.2.5. Serum institute of India Private Limited
8.2.6. Others

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Serum institute of India Private Limited
Note: Product cover images may vary from those shown
Adroll
adroll